Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroBioGen has developed and commercialized optimized Saccharomyces cerevisiae yeast strains that improve industrial bioprocess performance (yield, robustness, and by‑product value) for first- and second-generation bioethanol and related applications, including non-GM and GM strains used in commercial Innova yeast products with Novonesis and extended into baking, food and biochemicals through major licensing partnerships.[2][3][4][5][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroBioGen.